Bioavailability and pharmacokinetics comparison between generic and brand pravastatin in healthy subjects applying lc/ms/ms and labeled internal standard

• In: SIG: Bioavailability/Bioequivalence - Posters
• At: Basel (Switzerland) (2008)
• Type: Poster
• Poster code: BB-P-013
• By: AL-TAMIMI, Jaafar Jaber (Acdima BioCenter, Amman, Jordan)
• Co-author(s): Al-Nimry, Suhair (Acdima BioCenter, AMMAN, Jordan)
  Al-Yamani, Mahammad (Acdima BioCenter, AMMAN, Jordan)
  Akl, Marleine (Algorithm S.A.L., Lebanon)
  El Nakhel, Claude (Algorithm S.A.L., Lebanon)
  
• Abstract:

  Abstract
  
  Bioavailability and pharmacokinetics of a newly developed generic tablet formulation containing 40 mg Pravastatin sodium was compared with the established brand Lipostat® 40 mg tablets. The generic (test) and the brand (reference) products were administered to fifty healthy male adult subjects applying a single-dose, two-treatment,..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login